Geode Capital Management, LLC Immuno Gen, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.46 - $29.95 $6.02 Million - $14.5 Million	482,900 Added 9.86%	5,382,875 $160 Million
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $2.08 Million - $2.93 Million	147,425 Added 3.1%	4,899,975 $77.8 Million
Q2 2023 Aug 11, 2023	BUY	$3.75 - $20.05 $2.67 Million - $14.3 Million	713,154 Added 17.65%	4,752,550 $89.7 Million
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $735,123 - $985,505	200,306 Added 5.22%	4,039,396 $15.5 Million
Q4 2022 Feb 13, 2023	BUY	$4.55 - $6.31 $599,744 - $831,733	131,812 Added 3.56%	3,839,090 $19 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $96,306 - $139,085	21,497 Added 0.58%	3,707,278 $17.7 Million
Q2 2022 Aug 12, 2022	BUY	$3.15 - $5.76 $618,697 - $1.13 Million	196,412 Added 5.63%	3,685,781 $16.6 Million
Q1 2022 May 13, 2022	SELL	$4.26 - $7.48 $244,515 - $429,337	-57,398 Reduced 1.62%	3,489,369 $16.6 Million
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $629,004 - $993,165	132,422 Added 3.88%	3,546,767 $26.3 Million
Q3 2021 Nov 12, 2021	SELL	$5.02 - $6.59 $1.1 Million - $1.44 Million	-218,231 Reduced 6.01%	3,414,345 $19.4 Million
Q2 2021 Aug 13, 2021	BUY	$5.79 - $8.6 $670,395 - $995,751	115,785 Added 3.29%	3,632,576 $23.9 Million
Q1 2021 May 12, 2021	BUY	$6.5 - $10.53 $3.06 Million - $4.95 Million	470,188 Added 15.43%	3,516,791 $28.5 Million
Q4 2020 Feb 12, 2021	BUY	$3.7 - $7.66 $1.02 Million - $2.11 Million	275,364 Added 9.94%	3,046,603 $19.7 Million
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $82,627 - $117,115	-23,950 Reduced 0.86%	2,771,239 $9.98 Million
Q2 2020 Aug 13, 2020	BUY	$3.32 - $5.34 $200,640 - $322,717	60,434 Added 2.21%	2,795,189 $12.9 Million
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $667,248 - $2.14 Million	314,740 Added 13.01%	2,734,755 $9.32 Million
Q4 2019 Feb 13, 2020	BUY	$2.25 - $5.8 $223,463 - $576,038	99,317 Added 4.28%	2,420,015 $12.4 Million
Q3 2019 Nov 12, 2019	BUY	$2.22 - $3.39 $332,682 - $508,015	149,857 Added 6.9%	2,320,698 $5.62 Million
Q2 2019 Aug 14, 2019	BUY	$1.8 - $3.3 $551,217 - $1.01 Million	306,232 Added 16.42%	2,170,841 $4.71 Million
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $353,881 - $867,818	146,839 Added 8.55%	1,864,609 $5.05 Million
Q4 2018 Feb 13, 2019	BUY	$3.94 - $9.7 $382,116 - $940,744	96,984 Added 5.98%	1,717,770 $8.25 Million
Q3 2018 Nov 13, 2018	BUY	$8.6 - $11.26 $882,566 - $1.16 Million	102,624 Added 6.76%	1,620,786 $15.3 Million
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $4.3 Million - $5.49 Million	451,768 Added 42.36%	1,518,162 $14.8 Million
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $745,046 - $1.44 Million	111,201 Added 11.64%	1,066,394 $11.2 Million
Q4 2017 Feb 13, 2018	BUY	$5.07 - $7.92 $358,160 - $559,492	70,643 Added 7.99%	955,193 $6.12 Million
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $925,344 - $1.45 Million	171,360 Added 24.03%	884,550 $6.77 Million
Q2 2017 Aug 14, 2017	BUY	N/A	713,190	713,190 $5.07 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account